Blood component separation device and blood component separation method

US10940260B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10940260-B2
Application numberUS-201716086259-A
CountryUS
Kind codeB2
Filing dateMar 13, 2017
Priority dateMar 21, 2016
Publication dateMar 9, 2021
Grant dateMar 9, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a blood component separation device and related method, each capable of separating a blood component from blood and rapidly performing a virus inactivation process on the separated blood component. The blood component separation device includes a blood component separation section, provided in a centrifuge, configured to separate a blood component from blood by centrifugation, a diluting section configured to dilute, in a diluent containing riboflavin, concentrated red blood cells separated by the blood component separation section, and a UV light emitting unit configured to perform a virus inactivation process by exposing the concentrated red blood cells thus diluted to the UV light.

First claim

Opening claim text (preview).

The invention claimed is: 1. A blood component separation device, the device comprising: a centrifugal separation device; a blood component separation section configured to separate a blood component from blood by centrifugation; a diluting section configured to dilute, in a diluent containing a photoactive virus inactivation agent, the blood component separated by the blood component separation section; a blood-component virus inactivation section configured to perform a virus inactivation by exposing the diluted blood component to a UV light source; and a concentration adjustment section, wherein the blood component separation section and the concentration adjustment section are disposed within the centrifugal separation device. 2. The blood component separation device according to claim 1 , wherein the concentration adjustment section is configured to adjust a concentration of the blood component that has been subjected to the virus inactivation process. 3. The blood component separation device according to claim 2 , wherein the concentration adjustment section adjusts the concentration of the blood component by centrifuging the blood component. 4. The blood component separation device according to claim 3 , wherein the blood component separation section and the concentration adjustment section are provided in a same centrifugal separation section of the centrifugal separation device. 5. The blood component separation device according to claim 2 , wherein the concentration adjustment section includes a filter, and wherein the concentration of the blood component is adjusted by flowing the blood component into the filter in one direction to catch the blood component in the filter, and then flowing a liquid component in an opposite direction across the filter to collect the blood component. 6. The blood component separation device according to claim 1 , wherein the blood component is concentrated red blood cells. 7. The blood component separation device according to claim 1 , wherein the blood component is platelets. 8. The blood component separation device according to claim 6 , further comprising a plasma virus inactivation section configured to perform a virus inactivation process on plasma separated by the blood component separation section. 9. The blood component separation device according to claim 6 , further comprising a platelet virus inactivation section configured to perform a virus inactivation process on platelets separated by the blood component separation section. 10. A blood component separation method, the method comprising: separating a blood component from blood by centrifugation; diluting, in a diluent containing a photoactive virus inactivation agent, the separated blood component; performing a virus inactivation by exposing the diluted blood component to a UV light; and adjusting a concentration of the blood component subjected to UV light, wherein the separating of the blood component from blood and the adjusting of the concentration of the blood component subjected to UV light occur in a single centrifugal separation device. 11. The method of claim 10 , wherein the adjusting of the concentration of the blood component subjected to UV light is performed using a filter. 12. The method of claim 10 , wherein the separating of the blood component from blood and the adjusting of the concentration of the blood subjected to UV light are provided in a same centrifugal separation section of centrifugal separation device.

Assignees

Inventors

Classifications

  • using separation based on different densities of components, e.g. centrifuging · CPC title

  • Red blood cells; Erythrocytes · CPC title

  • by using a centrifuge · CPC title

  • Platelets; Thrombocytes · CPC title

  • Combination of filters with centrifugal separation devices · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10940260B2 cover?
Provided is a blood component separation device and related method, each capable of separating a blood component from blood and rapidly performing a virus inactivation process on the separated blood component. The blood component separation device includes a blood component separation section, provided in a centrifuge, configured to separate a blood component from blood by centrifugation, a dil…
Who is the assignee on this patent?
Terumo Corp
What technology area does this patent fall under?
Primary CPC classification A61M1/3683. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).